Luxembourg - Renin-Angiotensin System Medicine Use
Since 2014, Luxembourg Renin-Angiotensin System Medicine Use was down by 1.5% year on year. In 2019, the country was ranked number 25 among other countries in Renin-Angiotensin System Medicine Use with 97.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Luxembourg is overtaken by Israel, which was number 24 at 104.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Turkey at 87.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary topped the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 0.6% versus 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria recorded the best 5 years average growth at +10.2% per year, while Chile witnessed the worst performance at -3.5% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 97.50 |
2018 | 97.10 |
2017 | 98.60 |
2016 | 99.70 |
2015 | 102.40 |
How does Luxembourg rank in Renin-Angiotensin System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
24 |
#24
Israel
|
105 | 2019 | -2.2 % | -1.9 % | View data | |
25 |
#25
Luxembourg
|
98 | 2019 | +0.4 % | -1.4 % | View data | |
26 |
#26
Turkey
|
88 | 2019 | +0.5 % | +3.1 % | View data |